Providence Medical Technology closed a US $10.5MM debt agreement that will support distribution of cervical fusion technology in U.S. and ex-U.S. markets.
Vericel entered into a license agreement whereby Innovative Cellular Therapeutics will obtain exclusive rights to develop and distribute Carticel® and MACI® in Southeast Asia.
Life Spine received FDA 510(k) clearance of its CRANIAL FUSION system, expanding indications for use of SOLSTICE Polyaxial Screws into the cervical spine.
Conventus Orthopaedics completed a US $20MM equity financing. Funds will support commercialization of proximal humerus fracture repair technology and the development of the Conventus Cageâ„¢ intramedullary implant.